Introduction
============

Physical activity (PA) is essential to maintain health in healthy and elderly people, especially in patients with chronic conditions.[@b1-copd-12-105] PA makes its effect on patients through physiological and psychological mechanisms, such as fall of blood pressure and improvement of depression and anxiety.[@b2-copd-12-105] Patients with COPD are commonly found to be physically inactive, compared with healthy subjects.[@b3-copd-12-105]

Long-term difficulty in breathing reduces exercise ability in patients with COPD leading them to perform only their regular activity,[@b4-copd-12-105] and the prevalence of physical inactivity increases with the severity of COPD.[@b5-copd-12-105],[@b6-copd-12-105] COPD was recently characterized as a preventable and treatable disease, with significant systemic consequences.[@b7-copd-12-105],[@b8-copd-12-105]

However, physical inactivity is considered to be causing the systemic consequences of COPD,[@b9-copd-12-105] such as osteoporosis, weakness of skeletal muscle, and cardiovascular diseases.[@b10-copd-12-105] In addition, physical inactivity would increase the rate of hospital admission,[@b11-copd-12-105] and lead to decline in lung function.[@b12-copd-12-105] A previous epidemiologic study showed that physical inactivity is positively associated with the mortality of patients with COPD.[@b11-copd-12-105] PA and self-efficacy are the core components of pulmonary rehabilitation.[@b13-copd-12-105],[@b14-copd-12-105] PA is associated with self-efficacy, and increasing PA is related to improvements in psychological functioning and quality of life.[@b11-copd-12-105],[@b15-copd-12-105],[@b16-copd-12-105]

Recently, an increasing number of studies have focused on the effects of PA, screening of physical inactivity, and interventions for increasing PA, aimed to promote the development of recommendations that insist PA requirements to be taken into account for patients with COPD.[@b17-copd-12-105],[@b18-copd-12-105] However, there is lack of specific tools for an effective and quick assessment of PA in patients with COPD.[@b19-copd-12-105] Obviously, finding a reliable and valid tool to assess PA in patients with COPD is the first and crucial step for further study.

There are two different approaches for assessing PA: objective approach including accelerometers and pedometers, and subjective approach mainly including questionnaires. Although objective approach can provide more precise measurements and is widely used for quantifying PA, compared with questionnaires, it is less practical to be used in clinical settings and is unable to distinguish different domain-specific activities.[@b20-copd-12-105] Otherwise, questionnaires are inexpensive and not reactive to respondent's behavior,[@b21-copd-12-105] and are being widely applied in large-scale studies.[@b22-copd-12-105]

Recently, a systematic review showed that there were 13 PA questionnaires for the elderly until 2009, among which only three showed good reliability, including Physical Activity Scale for the Elderly (PASE). Compared with the two other questionnaires, PASE also showed good validity.[@b23-copd-12-105] PASE is especially designed for older adults, and is the commonly used self-report measurement of PA, mainly dealing with frequency, duration, and intensity of different activities.[@b24-copd-12-105] It has been validated and found to be reliable in several studies in older population,[@b25-copd-12-105],[@b26-copd-12-105] and in patients with end-stage renal disease and knee pain.[@b27-copd-12-105],[@b28-copd-12-105]

Recently, PASE has been translated into Chinese, and been confirmed to have acceptable reliability and validity in older Chinese population in Hong Kong.[@b29-copd-12-105],[@b30-copd-12-105] PASE mainly comprises three components -- leisure time (six questions), household (three questions), and work-related activities (one question) -- which are relevant to patients with COPD.

To our knowledge, PASE has not been validated among Chinese patients aged 60 years or older with COPD. The aim of the this study was to assess the validity and reliability of the Chinese version of PASE (PASE-C) in patients with COPD, including test−retest reliability and measurement error, content validity, concurrent validity, criterion validity, and construct validity.

Methods
=======

Patients
--------

A double-center study was conducted in two tertiary hospitals in Tianjin, People's Republic of China. A total of 167 outpatients with COPD were recruited in this study from May 2015 to February 2016. The diagnosis of COPD was based on 2016 GOLD (Global Initiative for Chronic Obstructive Lung Disease) guidelines.[@b31-copd-12-105] Patients were eligible if they met the following criteria: 1) aged 60 years or older, 2) stable and having COPD with respiratory symptoms (dyspnea, cough, and sputum production) within normal day-to-day variation, and with no change in medication within the last four weeks, 3) able to understand and write Chinese, and 4) volunteering to participate and sign written informed consent. Exclusion criterion was having some disorders or progressive diseases (rheumatoid arthritis, cancer within the last five years, severe heart disease, severe osteoporosis, stroke, or multiple sclerosis), influencing daily life seriously.

Procedure
---------

This study was approved by the Research Ethics Committee of the Tianjin Medical University. All outpatients were informed about the purpose and process of this study, and signed written informed consent was obtained from them. Participants completed a series of six instruments: demographic information, PASE-C and International Physical Activity Questionnaire-Short (IPAQ-S) to measure PA, Self-Efficacy for Managing Chronic Disease 6-Item Scale (SES6) to measure self-efficacy, Hospital Anxiety and Depression Scale (HADS) to measure mood status, and Medical Outcomes Study 36-Item Short Form Health Survey (SF-36) to measure health status. All participants completed these questionnaires at test session 1, and 35 participants were randomly selected to carry pedometer for seven consecutive days, and they completed the PASE-C again after they returned the pedometer at test session 2. All participants received the same instructions from the same researcher, and participants who were selected to carry pedometer were asked to maintain their usual PA during the time period.

Measures
--------

The demographic variables included age, gender, marital status, education level, career, employment status, salary, place of residence, smoking status, and drinking status. The clinical variable included body mass index, heart rate, grip strength (kg), duration of COPD (months), comorbidities, grade of dyspnea (measured by the modified British Medical Research Council \[mMRC\] scale), frequency of exacerbation in the last year, forced expiratory volume in one second (FEV~1~) as percentage of predicted (FEV~1~% pred), and GOLD grade (according to GOLD 1 \[mild\]: FEV~1~≥80% predicted, GOLD 2 \[moderate\]: 50%≤FEV~1~\<80% predicted, GOLD 3 \[severe\]: 30%≤FEV~1~\<50% predicted, GOLD 4 \[very severe\]: FEV~1~\<30% predicted).[@b32-copd-12-105]

PASE, used to assess PA for the elderly was designed by Washburn et al.[@b24-copd-12-105] Vaughan and Miller translated the original English PASE into Chinese according to a forward−backward procedure.[@b30-copd-12-105]

The PASE-C comprises three components: leisure time, household, and work-related activities. Leisure time activities include sitting (L1), walking outside the home (L2), light activities (L3), moderate activities (L4), strenuous activities (L5), and muscle strength/endurance exercise (L6). Household activities include light housework (H7), heavy housework (H8) and home repairs, lawn work/yard care, outdoor gardening, and taking care of another person (H9). Work-related activities include paid or volunteer work (W10). The PASE-C scores were computed according to the weights of each activity and an equation, multiplying the amount of time spent (hours/day during the previous seven days) and participation (yes or no), which ranged from 0 to 500 or more. The PASE-C had acceptable reliability and validity in older Chinese population.[@b30-copd-12-105]

Steps were tested by a pedometer (SP600; Shenzhenshi Sibowei Technology Co., Ltd, Shenzhen, People's Republic of China), which introduced the recent three-dimensional accelerometer transducer. The pedometer has a seven-day memory and records the total data, including the number of walking steps and energy expenditure per day. Patients carried the pedometers throughout the day, except while sleeping and bathing. The data for number of walking steps and energy expenditure for seven days were collected.

Grip strength was tested by a grip meter (WCS-100; Nantong Beisite Industry Co., Ltd, Jiangsu, People's Republic of China). When patients were in the standing position with their feet a foot apart and two arms in the natural prolapsed position, a grip meter was used to measure the grip strength of the dominant hand twice. The higher reading was chosen for analysis.

PA was evaluated by IPAQ-S which was designed to measure PA including walking, moderate activity, and vigorous activity during the previous seven days.[@b33-copd-12-105] Scores of the three levels of PA were calculated as frequencies and durations multiplied by known metabolic equivalent of task (MET): walking (3.3 METs), moderate activity (4.0 METs), and vigorous activity (8.0 METs). The scores of the three levels of PA were summed to obtain the total scores of IPAQ-S. IPAQ-S has been used among patients with COPD,[@b34-copd-12-105] and has acceptable convergent validity.[@b35-copd-12-105]

Self-efficacy was evaluated by SES6 which was designed to assess perceived self-efficacy in patients with chronic diseases.[@b36-copd-12-105] It is a six-item scale with score of each item ranging from 1 to 10, where 1 stands for no confidence and 10 stands for complete confidence. The total score is the average of the scores of the six items, which ranges from 1 to 10, with higher scores representing greater perceived self-efficacy.[@b36-copd-12-105] SES6 has been used among patients with COPD, and the Cronbach's α was 0.97.[@b37-copd-12-105]

Anxiety and depression were evaluated by HADS which was designed to measure mood disorders and identify the cases of anxiety and depression in patients with chronic diseases.[@b38-copd-12-105] This scale includes 14-item groups divided into two subscales, and odd numbers and even numbers are separately used to measure anxiety (HADS-A) and depression (HADS-D). For each subscale, the total score ranges from 0 to 21. According to previous studies, anxiety or depression symptoms are classified in those patients who score 11 or more, borderline anxiety and depression symptoms are classified in those patients who score from 8 to 10, and score lower than 7 indicates no clinically relevant symptoms.[@b39-copd-12-105],[@b40-copd-12-105] The HADS which has satisfactory reliability and validity[@b41-copd-12-105],[@b42-copd-12-105] has been widely used to assess anxiety and depression in patients with COPD.[@b43-copd-12-105],[@b44-copd-12-105]

Quality of life was evaluated by SF-36 which includes eight subscales: physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental health.[@b45-copd-12-105] The total scores of each subscale range from 0 to 100, and higher scores indicate good health status.[@b46-copd-12-105] In addition, SF-36 has been validated in patients with COPD; for subscales of SF-36, the test−retest reliability was acceptable with the Cronbach's α ranging from 0.75 to 0.99,[@b47-copd-12-105] and the construct validity against physician's evaluation of the patients' overall health status showed low-to-moderate correlations (*r*=0.29--0.55).[@b48-copd-12-105]

Statistical analysis
--------------------

### Cross-cultural adaptations

PASE-C has been obtained from Vaughan and Miller.[@b30-copd-12-105] A self-administered questionnaire is used in a new country or culture, and cross-cultural adaptations are essential to reach equivalence between original and target versions of the questionnaire.[@b49-copd-12-105] In different countries or cultures, a given PA may not be experienced, even if the PA is translatable, so the item would have to be replaced by a similar item that is experienced in the target culture, which is called experiential equivalence.[@b50-copd-12-105] Based on that, PASE-C was not tested in the People's Republic of China, and PASE-C was required to achieve experiential equivalence to be adapted by the subjects of the People's Republic of China. Three experts whose major was PA with at least five years of experience in independently conducting experiential equivalence, cited that some PAs are popularized in the People's Republic of China according to the Compendium of Physical Activities, a coding scheme that classifies PA by energy expenditure.[@b51-copd-12-105] The expert committee made critical decisions about the target version of PASE-C. For activities of walking, walking to buy breakfast was added into the examples. For light activities of sport and recreation, tai chi and yangko dance forms were added into the examples. For moderate activities of sport and recreation, brisk walking and flying kites were added into the examples. For strenuous activities of sport and recreation, playing badminton, skiing, and square dance were added into the examples.

All statistical analyses were conducted using IBM SPSS version 19.0 (SPSS, Chicago, IL, USA). For descriptive data, continuous variables were expressed as mean ± standard deviation (SD) or median (first to third quartiles, Q1−Q3) according to the Kolmogorov−Smirnov test, and categorical variables were expressed as relative frequencies and proportions. Significance level was set at a *P*-value of less than 0.05.

### Reliability

Reliability was tested by test−retest reliability and internal consistency. Test−retest reliability of the PASE-C was calculated using intraclass correlation coefficient (ICC) for absolute agreement between the PASE-C scores at test sessions 1 and 2. ICC scores greater than 0.75 indicated good reliability.[@b52-copd-12-105] Internal consistency of the scale was analyzed using Cronbach's coefficient α.

### Measurement error

In this research, measurement error was evaluated by the standard error of measurement (SEM), minimal detectable change (MDC), and limits of agreement (LoAs). SEM was calculated from the sample SD and the ICC of the scale according to the following formula: $$\text{SEM} = \text{SD}\sqrt{1 - \text{ICC}}.$$[@b53-copd-12-105]

MDC was calculated by the formula: $$\text{MDC} = 1.96 \times \sqrt{2} \times \text{SEM}.$$[@b54-copd-12-105]

LoAs were evaluated through the visual judgment of the relationship between the PASE-C scores of each test and retest using the Bland--Altman plot, which was performed using MedCalc Software bvba (version 16.4.3).[@b55-copd-12-105]

### Validity

The validity of PASE-C was based on content validity, concurrent validity, criterion validity, and construct validity. The content validity index (CVI) was separately evaluated by six experts (including three nurses and three doctors) and four patients. The experts were experienced in COPD and were familiar with the PA for COPD, and they had at least 10 years of working experience. The patients with at least five years' history of COPD met the inclusion and exclusion criteria of this study. The Likert 4-point scale was used, where "4" indicated "very much relevance", "3" indicated "strong relevance", "2" indicated "weak relevance", and "1" indicated "no relevance". The CVI was reflexed by item-content validity index (I-CVI), scale-content validity index/universal agreement (S-CVI/UA), and scale-content validity index/average (S-CVI/Ave). The S-CVI/UA is the number of items scaled 3 or 4 divided by the total number of items, and the S-CVI/Ave is the average of I-CVI of each item.[@b56-copd-12-105] The scale of I-CVI≥0.78 was considered acceptable,[@b57-copd-12-105] the S-CVI/UA\>0.8 showed good content validity,[@b58-copd-12-105] and the S-CVI/Ave was considered to overpass 0.9.[@b59-copd-12-105] Otherwise, experts were needed to provide explanation if they rated any item less than 3. The following are the formulas used for calculations of CVI.[@b56-copd-12-105] $$\begin{array}{l}
{\text{I-CVI} = \frac{\text{The~number~of~experts~rating}\ 3\ \text{or}\ 4}{\text{The~number~of~experts}}} \\
{\mspace{76mu} P_{c} = \frac{n!*0.5^{n}}{A!(n - A)!}} \\
{\mspace{76mu} K* = \frac{\text{I-CVI} - P_{c}}{1 - P_{c}}} \\
\end{array}$$where *P*~c~ is the probability of random correlation coefficient and *K*\* is the modified kappa coefficient and where *n* is the number of experts, and *A* is the number of experts who rated item 3 or 4. Concurrent validity was tested by the correlation with IPAQ-S, criterion validity was tested by the correlations with walking steps and energy expenditure, and construct validity was tested by the correlations with SES6, HADS, SF-36, grip strength, and disease characteristics. Pearson correlation coefficients and Spearman correlation coefficients were used to assess concurrent validity, criterion validity, and construct validity, where *r*\>0.60 represented high correlation, *r*=0.30--0.60 represented moderate correlation, and *r*\<0.30 represented low correlation.[@b60-copd-12-105] Based on the previous studies,[@b61-copd-12-105],[@b62-copd-12-105] we hypothesized that PASE-C scores have high correlation with IPAQ-S scores and have moderate-to-high correlation with walking steps and energy expenditure. The PASE-C scores were hypothesized to have moderate correlation with SES6, HADS, SF-36, and grip strength.[@b30-copd-12-105],[@b63-copd-12-105] We thought that there were correlations between the disease characteristics and the PASE-C scores.[@b64-copd-12-105],[@b65-copd-12-105]

Results
=======

Characteristics of participants
-------------------------------

A total of 167 outpatients with COPD were recruited in this study, with a mean age of 69.1±6.9 (range: 60--89) years. The demographic variables of patients with COPD are shown in [Table 1](#t1-copd-12-105){ref-type="table"}, and the clinical variables are shown in [Table 2](#t2-copd-12-105){ref-type="table"}. Among all, 35 outpatients completed the PASE-C twice and brought the pedometer with them for seven days.

Reliability
-----------

The PASE-C had an excellent seven-day test−retest reliability (ICC=0.98, 95% confidence interval: 0.96--0.99) and an acceptable internal consistency (Cronbach's α=0.71). For measurement error, the SEM and MDC values were 6.93 and 19.21, respectively. The Bland--Altman plot for the PASE-C score of test and retest is shown in [Figure 1](#f1-copd-12-105){ref-type="fig"}. The Bland--Altman plot nearly showed equal distribution on both sides of the zero line, and the upper LoA was 19.0 and the lower LoA was −21.0, of which two (6%) were not inside the LoA.

Validity
--------

The I-CVI values of the PASE-C items range from 0.70 to 1. Except for the I-CVI values of L6, H9, and W10 items, the I-CVI values of other items of this scale were 1. The S-CVI/Ave and S-CVI/UA values were 0.93 and 0.70, respectively. [Table 3](#t3-copd-12-105){ref-type="table"} shows each expert's ratings and calculation of CVI. For the lower I-CVI values of items, experts made some explanations. For L6 item, limited by the senility and disease, few patients had ability to do muscle strength/endurance exercise. For H9 item, home repair was a careful and time-consuming activity, which required some experts, and most patients lived in flat without garden, so they had little chance to do these activities. For W10 item, based on the Chinese work system, most people would retire when they are 60 years old, and volunteering is not popular in the People's Republic of China, so work- or volunteer-related activities had little association with PA of patients aged 60 years or older with COPD. However, in order to ensure the popularity of PASE-C among those aged less than 60 years, we did not delete these items.

For concurrent validity, PASE-C scores had correlation with IPAQ-S scores (*r*=0.651, *P*\<0.01). Criterion validity was confirmed by correlation with the walking steps (*r*=0.611, *P*\<0.01) and energy expenditure (*r*=0.493, *P*\<0.01). For construct validity, PASE-C scores had correlations with SES6 scores (*r*=0.396, *P*\<0.01), HADS-D scores (*r*=−0.234, *P*\<0.01), and seven subscales of SF-36 (*r*=0.182--0.525, *P*\<0.01). In addition, the PASE-C scores had associations with grip strength (*r*=0.341, *P*\<0.01), duration of COPD (*r*=−0.215, *P*\<0.01), mMRC scale (*r*=−0.354, *P*\<0.01), FEV~1~% pred (*r*=0.307, *P*\<0.01), and GOLD grade (*r*=−0.264, *P*\<0.01). [Table 4](#t4-copd-12-105){ref-type="table"} shows the correlations between the PASE-C scores and clinical variables.

Discussion
==========

For patients with COPD, physical inactivity is common compared to age-matched controls, and physical inactivity would worsen disease progression.[@b66-copd-12-105] Physical inactivity can predict the worse outcome of COPD, and has association with mortality and rate of hospital admission.[@b17-copd-12-105] Therefore, assessing and increasing PA are becoming increasingly important. The aim of this study was to evaluate PA in patients with COPD using the well-validated PASE-C. To our knowledge, this is the first study in which the psychometric properties of the PASE-C were tested in Chinese patients with COPD. The reliability and validity results showed that the PASE-C was a simple and useful tool to measure the PA of patients aged 60 years or older with COPD in the People's Republic of China.

In this study, the PASE-C scores were 73.25±49.47, which showed that the PA of patients aged 60 years or older with COPD was worse than that of general older people in the People's Republic of China (*t*=5.069, *P*\<0.001).[@b29-copd-12-105]

The ICC of PASE-C was 0.98, indicating that it had an excellent retest reliability.[@b52-copd-12-105]

The ICC was superior to the previous studies on elderly, which involved mail (*r*=0.84) and telephone samples (*r*=0.68) in the original study,[@b24-copd-12-105] and ICC was 0.65 in the Japanese translation study by Hagiwara et al[@b26-copd-12-105] and 0.79 in the Chinese translation study by Vaughan and Miller.[@b30-copd-12-105] A Cronbach's coefficient α greater than 0.7 is usually considered indicative of a reliable scale.[@b67-copd-12-105] So, our results confirmed that the PASE-C has an acceptable internal consistency.

Two patients were not inside the LoA on the Bland--Altman plot which showed that there was a reporting bias. One of the outliers reported his PA decreased due to the weather, while the other explained that he should take care of his wife who was admitted to hospital recently, which led to increase in his PA. These conditions could explain the difference between test and retest. Thus, in this study, the bias between test and retest was minimal. With high ICC value, there were little measurement error and narrow LoA, and so we consider that the reliability of PASE-C is excellent.

In this study, the PASE-C showed good content validity. As a criterion, the I-CVI≥0.78 indicated that the item has an acceptable content validity.[@b57-copd-12-105] However, the I-CVI of H9 was 0.70; hence, it is essential to make further modification. As in our previous hypothesis, concurrent validity was satisfactory due to PASE scores having high correlation with IPAQ-S scores, and criterion validity was acceptable due to PASE-C scores having high correlation with walking steps and moderate correlation with energy expenditure. For the construct validity, there were correlations between the PASE-C scores and SES6 scores, HADS-D scores, most of the subscales scores of SF-36, and disease characteristics, which mainly confirmed our previous hypotheses. So, the PASE-C showed satisfactory construct validity.

Limitations
===========

Although the results indicated that the PASE-C is suitable to assess the population in this study, there are several limitations that need to be addressed. First of all, the original PASE was designed for elderly aged 65 years or older in developed countries, but in the People's Republic of China, the elderly are defined as people aged 60 years or older. In this study, the participants were aged 60 years or older, which would influence the generalization in the world. Second, PASE-C scores had low correlations with HADS-D scores and some subscales scores of SF-36, which may be because HADS and SF-36 are not specific to patients with COPD, and it is essential to select more specific questionnaires in future study. Third, pedometer may underestimate or overestimate PA, so in order to test the validity of PASE more accurately, future study could use GOLD standard measures of PA as the criterion validity.

Conclusion
==========

The PASE-C has shown acceptable psychometric properties for assessing the PA in patients aged 60 years or older with COPD. Therefore, it is a good method to evaluate PA in patients with COPD, and it can be popularized in the future based on its convenience and effectiveness.
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###### 

Demographic variables of patients with COPD (N=167)

  Variables                  Number   Percent
  -------------------------- -------- ---------
  Gender                              
   Female                    60       35.9
   Male                      107      64.1
  Marital status                      
   Single                    9        5.4
   Married                   158      94.6
  Education level                     
   Elementary or lower       50       29.9
   Junior high               51       30.5
   Senior high               37       22.2
   College or higher         29       17.4
  Career                              
   Worker                    110      65.9
   Nonworker                 57       34.1
  Employment status                   
   Employed                  18       10.8
   Unemployed                149      89.2
  Salary (Yuan/month)                 
    ≤500                     22       13.2
   501--1,500                15       9.0
   1,501--3,000              65       38.9
    ≥3,001                   65       38.9
  Place of residence                  
   Countryside               33       19.8
   City                      134      80.2
  Smoking status                      
   Never                     57       34.1
   Ex-smoking                80       47.9
   Smoking                   30       18.0
  Drinking status                     
   Never                     75       44.9
   Ex-drinking               50       29.9
   Drinking                  42       25.2
  Comorbidities                       
   Hypertension              47       28.1
   Asthma                    34       20.4
   Pulmonary heart disease   33       19.8
   Coronary heart disease    27       16.2
   Bronchiectasis            16       9.6
   Diabetes                  19       11.4
   Others                    4        2.4

###### 

Clinical variables of patients with COPD (N=167)

  Variables                          Number (percent)   Mean (SD)/median (Q1--Q3)   Range
  ---------------------------------- ------------------ --------------------------- ----------------
  BMI (kg/m^2^)                      167                23.98 (4.08)                14.87--36.89
  Heart rate (bpm)                   167                77 (70--84)                 53--120
  Duration of COPD (months)          167                60 (36--90)                 3--240
  mMRC scale                         167                1 (1--2)                    0--4
  Frequency (in the last year)       167                1 (1--2)                    0--5
  FEV~1~% pred                       167                48.40 (18.75)               9.40--98.00
  GOLD grade                                                                        
   1                                 12 (7.2)                                       
   2                                 61 (36.5)                                      
   3                                 60 (35.9)                                      
   4                                 34 (20.4)                                      
  Grip strength (kg)                 167                24.6 (9.2)                  1.6--54.5
  PASE-C scores                      167                73.25 (49.47)               0--246.82
   Males                             107                72.29 (49.64)               0--195.80
   Females                           60                 74.95 (49.55)               0--246.82
  IPAQ scores (MET-min)              167                23.30 (10.00--36.57)        0--208.00
  SES6 scores                        167                7.50 (5.67--8.33)           1.83--10.00
  Total scores of HADS               167                7 (3--12)                   0--34
   HADS-A                                               2 (0--5)                    0--18
   HADS-D                                               4 (2--7)                    0--19
  SF-36                              167                                            
   PF                                                   75.00 (50.00--90.00)        0--100
   RP                                                   50.00 (0--100.00)           0--100
   RE                                                   100.00 (33.33--100.00)      0--100
   BP                                                   100.00 (74.00--100.00)      12--100
   VT                                                   70.00 (50.00--75.00)        15--90
   SF                                                   77.78 (55.56--100.00)       0--100
   MH                                                   76.00 (64.00--84.00)        20--100
   GH                                                   45.00 (30.00--62.00)        0--92
  Walking steps                      35                 23,788 (13,545--34,872)     3,000--58,691
  Energy expenditure (kcal/weight)   35                 980.6 (464.8--1,522.0)      105.0--3,387.3

**Abbreviations:** SD, standard deviation; Q, quartile; bpm, beats per minute; BMI, body mass index; mMRC, modified British Medical Research Council; FEV~1~% pred, forced expiratory volume in one second as percentage of predicted; GOLD, Global Initiative for Chronic Obstructive Lung Disease; PASE-C, Chinese version of Physical Activity Scale for the Elderly; IPAQ, International Physical Activity Questionnaire; MET, metabolic equivalent of task; SES6, Self-Efficacy for Managing Chronic Disease 6-Item Scale; HADS, Hospital Anxiety and Depression Scale; HADS-A, HADS for Anxiety; HADS-D, HADS for Depression; SF-36, Medical Outcomes Study 36-Item Short Form Health Survey; PF, physical functioning; RP, role-physical; RE, role-emotional; BP, bodily pain; VT, vitality; SF, social functioning; MH, mental health; GH, general health.

###### 

Each expert's rating and calculation of CVI

  Item   Expert rating   Number of three or four items   I-CVI   *P*~c~   *K*\*   Evaluation                                              
  ------ --------------- ------------------------------- ------- -------- ------- ------------ --- --- --- --- ---- ------ ------- ------ -----------
  L1     4               4                               4       4        4       4            4   4   4   4   10   1      0.001   1      Excellent
  L2     4               4                               4       4        4       4            4   4   4   4   10   1      0.001   1      Excellent
  L3     4               4                               4       3        4       3            4   4   4   4   10   1      0.001   1      Excellent
  L4     3               4                               4       3        4       3            4   4   4   4   10   1      0.001   1      Excellent
  L5     3               3                               4       3        3       3            4   4   4   4   10   1      0.001   1      Excellent
  L6     3               3                               3       3        2       3            4   2   3   3   8    0.80   0.044   0.79   Excellent
  H7     4               4                               4       4        4       4            4   4   4   4   10   1      0.001   1      Excellent
  H8     4               4                               4       4        3       4            4   4   4   4   10   1      0.001   1      Excellent
  H9     2               4                               3       3        2       3            3   2   4   3   7    0.70   0.117   0.66   Good
  W10    3               4                               3       2        2       3            3   3   4   3   8    0.80   0.044   0.79   Excellent

**Notes:** According to the criteria for *K*\*, \>0.74 is considered excellent, 0.60--0.74 good, and 0.40--0.59 fair. *P*~c~, probability of random correlation coefficient; *K*\*, modified kappa coefficient.

**Abbreviations:** CVI, content validity index; I-CVI, item-content validity index.

###### 

Correlations between the PASE-C scores and clinical variables

  Variables                          *r*      *P*-value
  ---------------------------------- -------- -----------
  Age (years)                        −0.231   0.003
  BMI (kg/m^2^)                      0.025    0.749
  Heart rate (bpm)                   −0.040   0.609
  Duration of COPD (months)          −0.215   0.005
  mMRC scale                         −0.354   0.000
  FEV~1~% pred                       0.307    0.000
  GOLD grade                         −0.264   0.001
  Walking steps                      0.611    0.000
  Energy expenditure (kcal/weight)   0.493    0.003
  Grip strength (kg)                 0.341    0.000
  IPAQ                               0.651    0.000
  SES6                               0.396    0.000
  HADS                                        
   HADS-A                            −0.149   0.055
   HADS-D                            −0.234   0.002
  SF-36                                       
   PF                                0.525    0.000
   RP                                0.218    0.005
   RE                                0.182    0.019
   BP                                0.030    0.699
   VT                                0.491    0.000
   SF                                0.475    0.000
   MH                                0.246    0.001
   GH                                0.443    0.000

**Abbreviations:** PASE-C, Chinese version of Physical Activity Scale for the Elderly; BMI, body mass index; mMRC, modified British Medical Research Council; FEV~1~% pred, forced expiratory volume in one second as percentage of predicted; GOLD, Global Initiative for Chronic Obstructive Lung Disease; IPAQ, International Physical Activity Questionnaire; SES6, Self-Efficacy for Managing Chronic Disease 6-Item Scale; HADS, Hospital Anxiety and Depression Scale; HADS-A, HADS for Anxiety; HADS-D, HADS for Depression; SF-36, Medical Outcomes Study 36-Item Short Form Health Survey; PF, physical functioning; RP, role-physical; RE, role-emotional; BP, bodily pain; VT, vitality; SF, social functioning; MH, mental health; GH, general health.

[^1]: These authors contributed equally to this work
